BR112015011957A2 - formulação pulverulenta - Google Patents

formulação pulverulenta

Info

Publication number
BR112015011957A2
BR112015011957A2 BR112015011957A BR112015011957A BR112015011957A2 BR 112015011957 A2 BR112015011957 A2 BR 112015011957A2 BR 112015011957 A BR112015011957 A BR 112015011957A BR 112015011957 A BR112015011957 A BR 112015011957A BR 112015011957 A2 BR112015011957 A2 BR 112015011957A2
Authority
BR
Brazil
Prior art keywords
powder formulation
powder
formulation
fatty acids
fine particle
Prior art date
Application number
BR112015011957A
Other languages
English (en)
Inventor
Su Gang
Mai Jimbin
Oliver Velarde Pena Pablo
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BR112015011957A2 publication Critical patent/BR112015011957A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01—Other fatty acid esters, e.g. phosphatides
    • A23D7/011—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/02—Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
    • A23D9/04—Working-up
    • A23D9/05—Forming free-flowing pieces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Fats And Perfumes (AREA)

Abstract

formulação pulverulenta a presente invenção refere-se a uma formulação pulverulenta compreendendo partículas em pó. estas partículas em pó compreendem óleos poliinsaturados, especialmente ácidos graxos poliinsaturados, e o pó tem ao mesmo tempo um excelente perfil sensorial, uma estrutura de partículas finas e uma elevada carga de óleo.
BR112015011957A 2012-11-28 2013-11-28 formulação pulverulenta BR112015011957A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261730636P 2012-11-28 2012-11-28
PCT/EP2013/075007 WO2014083124A1 (en) 2012-11-28 2013-11-28 Powderous formulation

Publications (1)

Publication Number Publication Date
BR112015011957A2 true BR112015011957A2 (pt) 2017-07-11

Family

ID=49681028

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015011957A BR112015011957A2 (pt) 2012-11-28 2013-11-28 formulação pulverulenta

Country Status (7)

Country Link
US (1) US9918952B2 (pt)
EP (1) EP2925153A1 (pt)
JP (1) JP2016503303A (pt)
KR (1) KR20150089015A (pt)
CN (1) CN104812250A (pt)
BR (1) BR112015011957A2 (pt)
WO (1) WO2014083124A1 (pt)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA899710A (en) * 1972-05-09 H. Bundus Robert Fat containing injected gas
JPH0716598B2 (ja) * 1987-05-26 1995-03-01 雪印乳業株式会社 油脂類の乳化方法
JPH0748992B2 (ja) * 1990-04-16 1995-05-31 日本油脂株式会社 血栓防止用粉末組成物
US6428832B2 (en) * 1996-03-26 2002-08-06 Dsm N.V. Late addition of PUFA in infant formula preparation process
EP1270710A1 (en) 2001-06-19 2003-01-02 Feyecon Development & Implementation B.V. A method of processing lipid materials
EP1757361A1 (en) * 2005-08-23 2007-02-28 Feyecon Development & Implementation B.V. Process for the preparation of encapsulates through precipitation
NL2002046C (en) * 2008-10-01 2010-04-02 Friesland Brands Bv Double emulsion and method to produce such.
EP2181604A1 (en) * 2008-11-04 2010-05-05 Feyecon Development & Implementation B.V. Dispersion structuring agent
WO2010149759A1 (en) * 2009-06-24 2010-12-29 Basf Se Microparticles comprising a fat soluble fraction comprising dha and their production
WO2011134627A1 (en) 2010-04-30 2011-11-03 Loders Croklaan B.V. Edible oil composition

Also Published As

Publication number Publication date
US20150320714A1 (en) 2015-11-12
EP2925153A1 (en) 2015-10-07
KR20150089015A (ko) 2015-08-04
US9918952B2 (en) 2018-03-20
WO2014083124A1 (en) 2014-06-05
JP2016503303A (ja) 2016-02-04
CN104812250A (zh) 2015-07-29

Similar Documents

Publication Publication Date Title
IL282844A (en) METHODS, PREPARATIONS AND DEVICES FOR SUPPLYING DIETARY ACID NEEDS
BR112016023676A2 (pt) pó de sinterização com baixa pressão
HK1216611A1 (zh) 白蛋白和紫杉醇的納米顆粒組合物
WO2014013335A3 (en) Concentration of omega-3 polyunsaturated fatty acids in krill oil
EP3056090A4 (en) Oil/fat composition containing polyunsaturated fatty acid
PL2956531T3 (pl) Kompozycje woskowe i wpływ metali na szybkość spalania
EP2961729A4 (en) PREPARATION OF BIOPOLYL ESTERS FOR LUBRICANTS APPLICATION
HK1205645A1 (en) Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids rrr-
WO2014057362A3 (en) Omega -3 compositions
EP3072397A4 (en) Powdered oil or fat composition and process for producing same
WO2014140873A3 (en) Omega- 3 phospholipid supplements for improved brain maturity
MY195213A (en) Release Agent Composition
BR112016007762A2 (pt) “lubrificante para metalurgia do pó e composições de pó de metal contendo dito lubrificante
SG11201704017QA (en) Lubricating oil compositions containing encapsulated microscale particles
SG10201701906VA (en) Diels alder based estolide and lubricant compositions
EP3049066A4 (en) Compositions and methods for the manufacture of lipid nanoparticles
IN2013MU03641A (pt)
EP3057579A4 (en) Carbohydrate-containing dietary compositions and methods for their preparation and use
PH12014501144A1 (en) Oil-in-water cosmetic compositions
GEP201706765B (en) Formulation for personal hygiene
PL3346980T3 (pl) Lipofilowe kompozycje kosmetyczne zawierające estry kwasu pelargonowego
IN2014DN05811A (pt)
MX2021001790A (es) Composiciones solidas de trigliceridos y usos de estas.
HUE037991T2 (hu) Sztearidonsavat és olívaolajat tartalmazó ehetõ lipid készítmények
BR112015011957A2 (pt) formulação pulverulenta

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements